Dr Franziska Huber | Fieldfisher
Skip to main content
Professional background

Professional background

My main areas of practice
Our clients include national and international companies. My particular focus is on advising pharmaceutical companies and manufacturers of medical devices on regulatory matters. I also provide support in the negotiation and drafting of various types of contracts in the Life Sciences sector.

In addition, as part of the Life Science Regulatory Practice Group at Fieldfisher, I advise on market access, particularly with regard to reimbursement and pricing of medicinal products and medical devices in the inpatient and outpatient service sector of the SHI, including method assessment procedures before the G-BA as well as negotiations with statutory health insurance funds and the SHI-SV.

The regulatory advisory practice includes in particular the placing on the market of medicinal products and medical devices (conformity assessment procedures, marketing authorisation, distribution, GDP, contracts between actors in the supply chain), wholesale authorisations, compassionate use and single importation, clinical trials and good manufacturing practice.

I advise our clients in German and English.

Personal engagement  
I am involved as an editor at breakingthrough and am a member of the DJB.

I am a lecturer at the University of Augsburg for Pharmaceutical and Medical Device Law.

My background
I studied in Augsburg and worked there as the Managing Director of the Institute for Bio-, Health- and Medical Law at the University of Augsburg during my doctorate on a Medical Law topic.

After my legal clerkship, which included a stop in Washington D.C., I worked as a lawyer in an international law firm in the Life Sciences and Private Equity sector.
 
 

Authored pieces

All Resources
Abstract representation of a chemical structure on a gradient purple and blue background. The molecular diagram features various bonded elements and hexagonal shapes, highlighting nitrogen (N) and amine (NH) groups.
Life Sciences
Insight

Small Gifts, Strict Rules: What the One-Euro Limit Means for Product-Related Advertising in the German MedTech Industry

25.07.2025
The German Federal Court of Justice (BGH) issued a key ruling on 17 July 2025 (Case I ZR 43/24), confirming that promotional gifts in product-related advertising for medical devices must not exceed a value of 1 Euro. This decision overturns a previous assumption by the Higher Regional Court of Hamburg, which had accepted a 5 Euro limit.
Learn more
A digital representation of a DNA double helix, with glowing particles forming the iconic twisted ladder shape. The background is a gradient of blue and purple, giving a futuristic and scientific feel to the image.
Insight

Update on the new Art. 10a MDR

10.12.2024
Learn more
Close-up of multiple pipettes dispensing blue liquid into rows of small, transparent test tubes in a laboratory setting. The scene is well-lit, emphasizing the precision and sterility of the scientific equipment and process.
Life Sciences
Insight

New MDR/IVDR amendment: transitional provisions for IVDs, EUDAMED, new Art. 10a

06.08.2024
Learn more
A digital illustration of a DNA double helix with a glowing purple and blue color scheme. Surrounding the DNA strand are interconnected lines and points forming a geometric network. The background is a dark gradient, enhancing the vibrant colors and the futuristic aesthetic.
Life Sciences
Insight

Artificial Intelligence and Medical Devices – Compliance with the AI Act

02.08.2024
Learn more
Press Release

Fieldfisher advises Sonova Retail Deutschland GmbH on the acquisition of Essen-based Hörsysteme Ansgar Wessling GmbH

07.02.2024
Sonova Retail Deutschland GmbH, part of the Swiss Sonova Group, a leading global provider of innovative hearing solutions, has made a strategic acquisition with the complete takeover of Hörsysteme Ansgar Wessling GmbH from Essen. Sonova received comprehensive legal advice on the transaction from a Fieldfisher team led by Partner Jan Hartmann and Counsel Slaven Kovacevic.
Learn more